Hepatitis C is a viral infection that affects the liver, caused by the Hepatitis C virus (HCV).

Individuals at risk of Hepatitis C infection or needing routine screening should undergo this test.

No, the test involves a simple blood draw, which may cause slight discomfort but is generally well-tolerated.

A positive result indicates the presence of antibodies against the Hepatitis C virus, suggesting either current or past infection.

No, additional tests such as HCV RNA PCR may be required to distinguish between acute and chronic infection.

Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.

The PT Test measures the time it takes for blood to clot, helping diagnose bleeding disorders and monitor anticoagulant therapy.

No, fasting is not required. However, inform your doctor about any medications you are taking.

Results are typically available within a few hours to 24 hours.

It ensures that the dosage of anticoagulant medication is within the therapeutic range to prevent bleeding or clotting complications.

Yes, it can help evaluate liver function and detect liver-related clotting factor deficiencies.